on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in HOOKIPA Pharma Inc.
The Vanguard Group Inc. has released a public disclosure under Form 8.3 related to its stake in HOOKIPA Pharma Inc. The company reported owning 213,222 common USD 0.0001 shares, representing 2.21% of the relevant securities.
This disclosure follows the rules set by the UK Takeover Code. Vanguard's disclosure confirms there are no other interests or parties involved in the offer related to HOOKIPA Pharma Inc.
No additional agreements concerning securities or derivatives were reported. The form, containing this position disclosure, was submitted on January 7, 2025. This information is crucial for stakeholders monitoring market positions of large institutional investors.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news